RGIA
ABBV icon

Rainier Group Investment Advisory’s AbbVie ABBV Stock Holding History

Rainier Group Investment Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$292K Buy
3,329
+473
+17% +$44.5K 0.12% 48
2020
Q2 		$280K Sell
2,856
-150
-5% -$13.2K 0.12% 42
2020
Q1 		$229K Buy
3,006
+734
+32% +$62.5K 1.49% 16
2019
Q4 		$201K Buy
+2,272
New +$189K 0.08% 48

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Rainier Group Investment Advisory's ABBV Position: Q3 2020 in Review

Rainier Group Investment Advisory increased its AbbVie (ABBV) stake by 17% in Q3 2020, buying an estimated $44.5K and bringing the position to 3,329 shares worth $292K. The position accounts for 0.12% of the portfolio, ranked #48.

Rainier Group Investment Advisory first reported a position in ABBV in Q4 2019 and has held it in 4 quarters since. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Rainier Group Investment Advisory held 3,329 shares of AbbVie worth $292K as of Q3 2020.
  • Rainier Group Investment Advisory bought 473 AbbVie shares in Q3 2020, an estimated $44.5K.
  • AbbVie made up 0.12% of Rainier Group Investment Advisory's portfolio in Q3 2020, its #48 holding.
  • Rainier Group Investment Advisory first reported a position in AbbVie in Q4 2019 and has held it in 4 quarters since.
  • 2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Rainier Group Investment Advisory's 13F filing for Q3 2020, filed 16 Nov 2020.